Igennem hele vaccinationsforløbet blev smerte rapporteret hos 66, 4% af de vaccinerede i Ambirix gruppen, sammenlignet med 63, 8% af de vaccinerede i 3 dosis kombinationsvaccine gruppen.
However, over the complete vaccination course, 66.4% of subjects who received Ambirix reported pain, as compared to 63.8% of subjects who received the three dose combined vaccine.